| Title : Effect of Anagliptin and Sitagliptin in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: What Is the Real REASON Behind It? - |
| Author(s) : Jonnalagadda VG , Char HP , Ankana PK |
| Ref : Cardiovasc Drugs Ther , 32 :311 , 2018 |
| PubMedID: 29516206 |